Skip to main content
  1. Market Insights
  2. Health
  3. Pharmaceuticals

Multiple Sclerosis Drugs - Colombia

Colombia
  • Colombia is expected to witness significant growth in the Multiple Sclerosis Drugs market.
  • By 2025, the projected revenue is estimated to reach US$40.59m.
  • This revenue is expected to exhibit an annual growth rate (CAGR 2025-2029) of 1.18%.
  • As a result, the market volume is anticipated to reach US$42.54m by 2029.
  • In comparison to other countries, United States is projected to generate the highest revenue of US$11.85bn in 2025.
  • Colombia's growing healthcare infrastructure and increasing government support are driving the demand for Multiple Sclerosis drugs in the country.

Definition:
This market covers drugs to treat the neurological autoimmune disease multiple sclerosis. As there is no cure for multiple sclerosis, the goal is to improve functions after an attack or to prevent attacks. Different types of medication include immunomodulators, immunosuppressants, and interferons. Monoclonal antibodies are now being increasingly used.

Additional information:
Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).

Company examples: Biogen, Roche, Novartis, Sanofi

In-Scope
  • Drugs to treat multiple sclerosis
  • Monoclonal antibodies
  • Immunosuppressants
Out-Of-Scope
  • Monoclonal antibodies and immunosuppressants for the treatment of other diseases
  • Treatment of other autoimmune diseases
  • Alternative medicine
Multiple Sclerosis Drugs: market data & analysis - Cover

Market Insights report

Multiple Sclerosis Drugs: market data & analysis
Study Details

    Revenue

    Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.

    Most recent update:

    Source: Statista Market Insights

    Notes: The chart “Comparable Estimates” shows the forecasted development of the selected market from different sources. Please see the additional information for methodology and publication date.

    Most recent update:

    Most recent update:

    Source: Statista Market Insights

    Analyst Opinion

    The Multiple Sclerosis Drugs market in Colombia has been showing interesting developments in recent years.

    Customer preferences:
    Colombian customers have shown a growing demand for Multiple Sclerosis Drugs due to the increasing prevalence of the disease in the country. Patients are becoming more aware of the available treatments and are seeking options that offer better efficacy and fewer side effects. Additionally, the preference for oral treatments over injectables has been growing, as patients seek more convenient and less invasive options.

    Trends in the market:
    The Multiple Sclerosis Drugs market in Colombia has been growing steadily in recent years, driven by the increasing prevalence of the disease and the growing availability of innovative treatments. The market has been dominated by established players, but there has been a growing number of new entrants offering innovative products that offer better efficacy and fewer side effects. The market has also seen a shift towards oral treatments, with a growing number of patients opting for these options over injectables.

    Local special circumstances:
    Colombia has a high prevalence of Multiple Sclerosis, with an estimated 9,000 cases in the country. However, access to treatment has been a major challenge, particularly for patients in rural areas. The government has implemented several initiatives to improve access to treatment, including the inclusion of Multiple Sclerosis Drugs in the national formulary and the implementation of programs to improve patient education and awareness.

    Underlying macroeconomic factors:
    Colombia has a growing economy, with a stable political environment and a well-developed healthcare system. The government has been investing heavily in healthcare infrastructure and has implemented several policies to improve access to healthcare for all citizens. Additionally, the country has a growing middle class, which has been driving demand for healthcare services, including Multiple Sclerosis Drugs. The pharmaceutical industry in Colombia is also growing, with several multinational companies establishing a presence in the country in recent years.

    Key Players

    Most recent update:

    Source: Statista Market Insights

    Global Comparison

    Most recent update:

    Source: Statista Market Insights

    Methodology

    Data coverage:

    Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

    Modeling approach / Market size:

    Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

    Forecasts:

    In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

    Additional notes:

    Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.

    Health

    Access more Market Insights on Health topics with our featured report

    Multiple Sclerosis Drugs: market data & analysis - BackgroundMultiple Sclerosis Drugs: market data & analysis - Cover

    Key Market Indicators

    Notes: Based on data from IMF, World Bank, UN and Eurostat

    Most recent update:

    Source: Statista Market Insights

    Explore more high-quality data on related topic

    Global pharmaceutical industry - statistics & facts

    The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.
    More data on the topic

    Contact

    Get in touch with us. We are happy to help.
    Meredith Alda
    Sales Manager

    Mon - Fri, 9am - 6pm (EST)

    Lodovica Biagi
    Director of Operations

    Mon - Fri, 9:30am - 5pm (GMT)

    Ayana Mizuno
    Junior Business Development Manager

    Mon - Fri, 10:00am - 6:00pm (JST)

    Carolina Dulin
    Group Director - LATAM

    Mon - Fri, 9am - 6pm (EST)

    Yolanda Mega
    Operations Manager

    Mon - Fri, 9am - 5pm (SGT)